相关实验视频

Updated: Jan 16, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

通过基于网络药理学和分子对接的SRC激活的抑制,研究基因因对LPS诱导的HPMEC功能障碍的影响

Jingchao Chen¹, Hao Pan², Jinchun Wang¹

¹Emergency center, the Third Affiliated Clinical Hospital of Changchun University of Traditional Chinese Medicine, No.1643, Jingyue Street, Changchun City, 130000, Jilin, China.

|September 30, 2025

概括

原蛋白通过向SRC通路来保护肺炎,改善肺细胞功能并减少损伤. 这种生物活性化合物为治疗成人肺炎提供了潜在的治疗点.

科学领域:

药理学药理学是指药理学的学科.
分子生物学分子生物学
细胞生物学细胞生物学

背景情况:

成人肺炎是一种传染性肺部感染,其机制尚未完全理解.
来自Polygala tenuifolia的tenuigenin具有不同的药理作用.
原在成人肺炎中的特定作用需要进一步阐明.

研究的目的:

调查Tenuigenin在成人肺炎中的治疗潜力.
为了确定Tenuigenin的分子点和肺炎中涉及的途径.
评估Tenuigenin对肺内皮细胞的保护作用.

主要方法:

生物信息学和网络药理学用于识别Tenuigenin目标.
在体外测试 (CCK8,EDU,Transwell,TER) 来评估细胞功能.
西方斑点和分子对接以验证目标相互作用.

主要成果:

原蛋白向调节血管透性和信号传递的途径.
原蛋白保护人类肺微血管内皮细胞 (HPMECs) 免受LPS诱导的损伤,亡和功能障碍.
类固醇受体联合激活剂 (SRC) 被确定为一个关键的标,调解Tenuigenin的保护作用.

结论:

原蛋白通过向SRC通路来缓解脂聚糖 (LPS) 诱导的HPMEC损伤.
原蛋白显示出作为成人肺炎治疗剂的潜力.
用tenuigenin针对SRC途径为肺炎管理提供了一种新的策略.

关键词:

成年人的肺炎.分子对接是分子对接.类固醇受体联合激活剂这就是Tenuigenin.

更多相关视频

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

相关概念视频

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Amplifying Signals via Enzymatic Cascade

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...